Cerity Partners’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Cerity Partners's EXEL Position: Q1 2026 in Review
Cerity Partners reduced its Exelixis (EXEL) stake by 10% in Q1 2026, selling an estimated $1.52M and leaving 313,945 shares worth $13.5M. The position accounts for 0.02% of the portfolio, ranked #576.
Cerity Partners first reported a position in EXEL in Q1 2024 and has held it in 9 quarters since. The position peaked at $15.3M in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Cerity Partners held 313,945 shares of Exelixis worth $13.5M as of Q1 2026.
- Cerity Partners sold 35,271 Exelixis shares in Q1 2026, an estimated $1.52M.
- Exelixis made up 0.02% of Cerity Partners's portfolio in Q1 2026, its #576 holding.
- Cerity Partners first reported a position in Exelixis in Q1 2024 and has held it in 9 quarters since.
- Cerity Partners's Exelixis position peaked at $15.3M in Q4 2025.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.